cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Dexcom Inc
198 own
36 watching
Current Price
$109.5
$2.77
(2.6%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
42,288.9M
52-Week High
52-Week High
134.765
52-Week Low
52-Week Low
66.8925
Average Volume
Average Volume
2.19M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
120.657
iconMarket Capitalization42,288.9M
icon52-Week High134.765
icon52-Week Low66.8925
iconAverage Volume2.19M
iconDividend Yield--
iconP/E Ratio120.657
What does the Dexcom Inc do?
DexCom, Inc., a medical device company, together with its subsidiaries, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Its products include DexCom G4 PLATINUM system for continuous use by adults with diabetes; DexCom G4 PLATINUM with Share, a remote monitoring system; and DexCom G5 Mobile, a CGM system that directly communicates to a patient's mobile and its data can be integrated with DexCom CLARITY, which is a next generation cloud-based reporting software for personalized, easy-to-understand analysis of trends to improve diabetes management. The company also offers sensor augmented insulin pumps. It has a collaboration and license agreement with Verily Life Sciences LLC to develop a series of next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. The company was founded in 1999 and is headquartered in San Diego, California.
Read More
How much money does Dexcom Inc make?
News & Events about Dexcom Inc.
Business Wire
1day ago
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today unveiled the companys second Super Bowl commercial, which announces the US launch of its next-generation Dexcom G7 CGM System. The ad, which will run during the second quarter of...
Ticker Report
12days ago
DexCom, Inc. (NASDAQ:DXCM Get Rating) CEO Kevin R. Sayer sold 45,607 shares of DexCom stock in a transaction on Friday, January 20th. The shares were sold at an average price of $105.75, for a total value of $4,822,940.25. Following the completion of the transaction, the chief executive ...
Zolmax
13days ago
DexCom, Inc. (NASDAQ:DXCM Get Rating) CEO Kevin R. Sayer sold 45,607 shares of the businesss stock in a transaction dated Friday, January 20th. The stock was sold at an average price of $105.75, for a total value of $4,822,940.25. Following the sale, the chief executive officer now directly owns 426...
Business Wire
1month ago
DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer, Chairman, President and Chief Executive Officer, will present an update on the company at the 41st annual J.P. Morgan Healthcare Conference on January 9, 2023. The live presentation is scheduled to begin at approximately 2:15 PM EST and...
Zolmax
1month ago
Shares of DexCom, Inc. (NASDAQ:DXCM Get Rating) have been assigned a consensus recommendation of Moderate Buy from the nineteen analysts that are currently covering the stock, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation and seven have assigned a ...
Frequently Asked Questions
Frequently Asked Questions
What is Dexcom Inc share price today?
plus_minus_icon
Can Indians buy Dexcom Inc shares?
plus_minus_icon
How can I buy Dexcom Inc shares from India?
plus_minus_icon
Can Fractional shares of Dexcom Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Dexcom Inc stocks?
plus_minus_icon
What is today’s traded volume of Dexcom Inc?
plus_minus_icon
What is today’s market capitalisation of Dexcom Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Dexcom Inc?
plus_minus_icon
What percentage is Dexcom Inc down from its 52-Week High?
plus_minus_icon
What percentage is Dexcom Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$109.5
$2.77
(2.6%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00